News Archive
The GW School of Medicine and Health Sciences and The GW Medical Faculty Associates have appointed Adam Friedman, MD, to serve as chair of the Department of Dermatology.
GW researchers found low dose aspirin may reduce the need for mechanical ventilation, ICU admission and in-hospital mortality in hospitalized COVID-19 patients. Final results indicating the lung protective effects of aspirin were published today in Anesthesia & Analgesia.
Suzan Song, MD, PhD, associate professor of psychiatry and behavioral sciences, spoke to DCist for an article about "pandemic fatigue" and how this leads some people to engage in riskier behaviors, like going to the Tidal Basin for the Cherry Blossom Festival, during the COVID-19 pandemic.
The GW Department of Dermatology received a $250,000 grant from Pfizer to expand accessible teledermatology for atopic dermatitis patients in Washington, D.C.
J. Keith Melancon, MD, medical director of the GW Ron & Joy Paul Kidney Center, director of the GW Transplant Institute, and professor of surgery, spoke to The Washington Post about kidney donation and transplantation.
U.S. News and World Report ‘Best Hospitals’ survey is underway and GW physicians are asked to voice their support for GW Hospital.
New new coverage Tier 1 within university employee medical plans dedicated to care provided by GW Medical Faculty Associates (MFA) providers, promises lower copayments and lower employee coinsurance when GW employee plan holders are seen by a GW MFA provider.
At the start of the 2020-21 academic year the George Washington University (GW) School of Medicine and Health Sciences (SMHS) and the SMHS Office of Diversity and Inclusion’s Anti-Racism Coalition (ARC) launched an educational series to increase understanding about issues related to race,…
The George Washington University (GW) School of Medicine and Health Sciences (SMHS) has selected Tamara “Tami” Ritsema, PhD, MPH, MMSc, PA-C, associate professor of physician assistant (PA) studies, to serve as the interim chair of the Department of PA Studies at GW SMHS, beginning on March 1,…
The George Washington University announced today its participation in a Sanofi COVID-19 vaccine clinical trial. GW was selected as one of approximately 25 sites in the United States to launch a phase 2 study for its adjuvanted recombinant protein-based COVID-19 vaccine candidate.